1. Possible Biomarkers for Cancer Immunotherapy
   Takehiro Otoshi et al, 2019, Cancers CrossRef
2. Serum cytokines predict efficacy and toxicity, but are not useful for disease monitoring in lung cancer treated with PD-(L)1 inhibitors
   Hannah Schindler et al, 2022, Frontiers in Oncology CrossRef
3. Sodium glucose co-transporter 2 (SGLT2) inhibition via dapagliflozin improves diabetic kidney disease (DKD) over time associatied with increasing effect on the gut microbiota in db/db mice
   Jiajia Wu et al, 2023, Frontiers in Endocrinology CrossRef